Pre-Conference Workshops (pm only) and Training Course (full day) - PT (Pacific Time, GMT-08:00)
Pre-Conference Workshops (pm only) and Training Course (full day)
- PT (Pacific Time, GMT-08:00)
8:00am - 9:00am60 mins
Training Course Registration
Optional Pre-Conference Training Course (9:00am-5:00pm) and Pre-Conference Workshops (1:00pm-5:00pm)
9:00am - 5:00pm480 mins
Training Course: Introduction to Antibody Engineering
Introduction to Antibody Engineering
- David Bramhill, PhD - Consultant, Bramhill Biological Consulting, LLC
10:00am - 10:10am10 mins
Early Career Scientist Session
Early Career Scientist Session Welcome and Opening Remarks
10:10am - 10:25am15 mins
Early Career Scientist Session
Early Career Scientist Presentation #1
10:25am - 10:40am15 mins
Early Career Scientist Session
Early Career Scientist Presentation #2
10:40am - 10:55am15 mins
Early Career Scientist Session
Early Career Scientist Presentation #3
10:55am - 11:10am15 mins
Early Career Scientist Session
Early Career Scientist Presentation #4
11:10am - 11:30am20 mins
Early Career Scientist Session
Mid-Career Scientist Career Perspectives, Lessons Learned
11:30am - 12:00pm30 mins
Early Career Scientist Session
Panel Discussion and Extended Q&A
1:00pm - 1:15pm15 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Co-Chairs' Remarks: Engineering Considerations for Candidate Selection and Developability
- Peyton Greenside, Ph.D. - Chief Scientific Officer and Co-founder, BigHat Biosciences
- Javier Chaparro-Riggers, Ph.D. - Vice President, BioMedicine Design, Pfizer
1:00pm - 1:15pm15 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Co-Chairs' Remarks: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
- Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
- Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
1:15pm - 1:45pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Optimizing Antibodies for Efficacy
- Javier Chaparro-Riggers, Ph.D. - Vice President, BioMedicine Design, Pfizer
1:15pm - 1:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Creating Value in Biotech: Insights from an Investor Turned Operator and Back Again
- Kelly Moynihan, PhD - VP, CSO Partner Team, Curie.Bio
1:45pm - 2:15pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Accelerating Biologics Discovery Through Early Developability Workflows and Tailored Strategies for Complex Formats
- Laurence Fayadat-Dilman, Ph.D. - Director, Protein Sciences, Merck Research Laboratories
1:45pm - 2:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Lessons Learned during the Transition from Preclinical to Early Clinical Development/Clinical POC
- Mohit Trikha, PhD - President & COO, Kivu Biosciences
2:15pm - 2:45pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Mitigation of Biopharmaceuticals Immunogenicity During Drug Design
- Sophie Tourdot - Immunogenicity Sciences Lead, Pfizer
2:15pm - 2:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Mixing and Matching: Partnering vs. Internal Development of Novel Antibodies
- Bassil Dahiyat, PhD - President and CEO, Xencor
2:45pm - 3:15pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Networking Refreshment Break
2:45pm - 3:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Networking Refreshment Break
3:15pm - 3:45pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Lab-in-the-loop Therapeutic Antibody Design with Deep Learning
- Nathan Frey, PhD - Machine Learning Scientist, Prescient Design, Genentech
3:15pm - 3:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
IP Strategies for Antibody Therapeutics
- Gargi Talukder, PhD - Partner, Orrick
3:45pm - 4:15pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Predicting Antibody Developability Using Interpretable Machine Learning
- Peter Tessier, PhD - Albert M. Mattocks Professor, Departments of Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan
3:45pm - 4:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Speaker TBA
4:15pm - 4:45pm30 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Machine Learning-driven Design of Next Generation Antibodies with Enhanced Functionality
- Noelle Huskey Mullin, PhD - Associate Director, Discovery Medicine, BigHat Biosciences
4:15pm - 4:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Panel Discussion
- Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
- Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
4:45pm - 5:00pm15 mins
Workshop 1: Engineering Considerations for Candidate Selection and Developability
Concluding Remarks
4:45pm - 5:00pm15 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Concluding Remarks
5:00pm - 5:05pm5 mins
Close of Workshops and Training Course
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.